uPAR-PET/MR in Glioblastoma Multiforme

Trial Profile

uPAR-PET/MR in Glioblastoma Multiforme

Phase of Trial: Phase II

Latest Information Update: 02 Apr 2018

At a glance

  • Drugs Gallium-68 NOTA AE105 (Primary)
  • Indications Glioblastoma
  • Focus Diagnostic use
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 04 Apr 2017 Status changed from not yet recruiting to recruiting.
    • 13 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top